14 - SUSTAIN 1: Efficacy and Safety of Once-Weekly Semaglutide Monotherapy vs. Placebo in Subjects with Type 2 Diabetes
- Resource Type
- Abstract
- Source
- In
Canadian Journal of Diabetes October 2016 40(5) Supplement:S6-S6 - Subject
- Language
- ISSN
- 1499-2671